Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Maryland, Baltimore
University of Kentucky
Dana-Farber Cancer Institute
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
University of Chicago
M.D. Anderson Cancer Center
University of Pittsburgh
University of Pittsburgh
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Arizona
University of Arizona
Merck Sharp & Dohme LLC
University of Pittsburgh
UNC Lineberger Comprehensive Cancer Center
Pfizer
University of Wisconsin, Madison
University of Kentucky
Karyopharm Therapeutics Inc
Vidac Pharma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
H. Lee Moffitt Cancer Center and Research Institute
Amgen
Baylor College of Medicine
Boston Scientific Corporation
University of Texas Southwestern Medical Center
Stanford University
University of Texas Southwestern Medical Center
UNC Lineberger Comprehensive Cancer Center
University of Rochester
University of Chicago
Karolinska University Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Daiichi Sankyo
National Institutes of Health Clinical Center (CC)
Amgen
M.D. Anderson Cancer Center
Emory University
National Cancer Institute (NCI)
University of Kansas Medical Center
Merck Sharp & Dohme LLC
University of Alabama at Birmingham
University of Miami
Amgen
Washington University School of Medicine
Stanford University